The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 15, 2024

Filed:

Feb. 03, 2017
Applicant:

The General Hospital Corporation, Boston, MA (US);

Inventors:

Ebru Oral, Newton, MA (US);

Jeremy V. Suhardi, Boston, MA (US);

Orhun K. Muratoglu, Cambridge, MA (US);

Henrik Malchau, Cambridge, MA (US);

Harry E. Rubash, Marco Island, FL (US);

Andrew A. Freiberg, Weston, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61L 31/16 (2006.01); A61K 45/06 (2006.01); A61L 27/34 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01); A61L 29/08 (2006.01); A61L 29/14 (2006.01); A61L 29/16 (2006.01); A61L 31/10 (2006.01); A61L 31/14 (2006.01); C08F 2/44 (2006.01); C08L 71/02 (2006.01); A61K 31/496 (2006.01); A61K 31/7052 (2006.01);
U.S. Cl.
CPC ...
A61L 31/16 (2013.01); A61K 45/06 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); A61L 29/085 (2013.01); A61L 29/148 (2013.01); A61L 29/16 (2013.01); A61L 31/10 (2013.01); A61L 31/148 (2013.01); C08F 2/44 (2013.01); C08L 71/02 (2013.01); A61K 31/496 (2013.01); A61K 31/7052 (2013.01); A61L 2300/418 (2013.01); A61L 2400/04 (2013.01);
Abstract

This present invention relates to drug eluting polymers, including novel biodegradable drug eluting polymers, which are added to the surface of a medical device to treat device associated complications and to deliver drug locally around the device. Methods of making polymers, for example, drug-eluting polymers, polymer compositions, and materials used therewith also are provided. The drug eluting polymers are obtained from the polymerization of macromonomers made of a connecting moiety, a biodegradable moiety and a cross-linkable moiety that are liquids at a temperature of 10° C. to 40° C.


Find Patent Forward Citations

Loading…